Backgroud: Current understanding of injury and regeneration of islet β-cells in diabetes is mainly based on rodent studies. The tree shrew is now generally accepted as being among the closest living relatives of primates, and has been widely used in animal experimentation. However, there are few reports on islet cell composition and regeneration of β-cells in tree shrews.
Current understanding of injury and regeneration of islet β-cells in diabetes is mainly based on rodent studies. Regeneration of islet β-cells in rodents has been confirmed using partial pancreatectomy, 4 ligation of the pancreatic duct 5 and other methods. Regeneration is dominated by replication of islet β-cells. However, regeneration of β-cells also occurs from precursor cells in the pancreatic duct. The regenerative function declines with age. 6, 7 Recently, Tomer et al 8 constructed a mouse model of diphtheria toxin tissue-specific transgene, in which diphtheria toxin was expressed in islet β-cells after application of doxycycline, resulting in apoptosis of 70%-80% of β-cells.
Shamsi et al 9 have also developed a mouse model based on β-cell-specific genetic ablation of the transcription initiation factor 1A (TIF-IA)
that induces a slow apoptotic response, eventually leading to protracted β-cell death. These models have provided a highly efficient method for studying replication and regeneration of islet β-cells.
In humans, growth and replication of β-cells mainly occurs in childhood. In adulthood, a few studies have found almost no evidence of β-cell replication. [10] [11] [12] [13] However, these results were mainly obtained from studies using cadavers or surgical specimens. Currently, it is impossible to directly detect the number of islet β-cells in a living human body, and assessment of β-cell function via measurement of insulin secretion is unlikely to accurately reflect the number of β-cells. Therefore, transplantation from human cadavers or biopsies into immunodeficient animals has been used to study the regeneration of islet β-cells in humans. [14] [15] [16] [17] [18] Interestingly, Suarez-Pinzon et al 18 found that human pancreatic duct cells in grafts introduced into diabetic mice had a large number of cells that were double stained for cytokeratin 19 (CK19) and insulin, and this number increased markedly to over 50% of the CK19 population after stimulation with gastrin and glucagon-like peptide 1 (GLP-1). These findings with double-stained cells provide evidence that neogenesis was active in these grafts and could be stimulated.
Transplantation of human tissues into immunodeficient mice is unlikely to exclude the role of the mouse's microenvironment, suggesting that specific factors in mice initiate changes in stationary cells, or ischemia and temperature variation during specimen transplantation affect the expression of Ki67 and other genes.
In vivo experiments in animals with pancreas tissue similar to humans in anatomy and function may alleviate the influence the microenvironment on tissue transplantation. The tree shrew is a small mammal that has been well-characterised in animal experimentation literature and is therefore highly appropriate for animal experiments. It is widely distributed in Southeast Asia and southwest China. Historically, it has been classified as a primate, but is now generally accepted as being among the closest living relatives of primates. 19 Fan et al 20 conducted germ-line genome analysis which found that the tree shrew is very closely related to primates.
Because of ethical concerns about primate research, the importance of the tree shrew as a laboratory animal has increased over the years. To date, the tree shrew has been extensively used in studies of hepatitis B and C infection, tumors, myopia, stress and depression, metabolic syndrome, as well as bacterial infection. 21 These include studies investigating the role of STZ-induced diabetes models, [22] [23] [24] which found that STZ destroyed islet β-cells and induced persistent diabetes in the tree shrew. Our study explored changes in islet structure, as well as regeneration of β-cells, after STZ treatment of tree shrews compared with rats, in an effort to provide basic data for application in studies on diabetes.
2 | METHODS
| Ethical approval
The experimental protocols were approved by the Institutional Ani- 
| Analysis of fasting blood glucose and serum insulin
Blood was maintained at room temperature for 30 minutes and centrifuged at 4000 g for 10 minutes. The supernatant was collected and preserved at −80°C until further use. Blood glucose analysis was performed using an automated biochemical analyzer (Toshiba120, Japan), and serum insulin analysis was performed using radioimmunoassay (xh6080, China).
| Immunohistochemical staining
Immunohistochemical staining was conducted using conventional Five visual fields were selected from each section for photography (20×). All the islets in each visual field were depicted using the ImagePro Plus pathological image analysis system, to calculate the islet number and islet area. Finally, the mean islet area and the mean islet number in each visual field were calculated for statistical analyses. 
| Statistical analyses
All the results were expressed as mean ± SD. Differences between means were tested for statistical significance using a one-way analysis of variance (ANOVA) and post hoc least significance tests. SPSS 13 program (SPSS ® , Chicago, USA) was used for all statistical analyses.
3 | RESULTS
| Changes in fasting blood glucose and serum insulin levels
The fasting blood glucose value is controlled by multiple factors, and is the key parameter for diagnosis of diabetes. STZ treatment decreased insulin levels following injury to a large number of islet β-cells, resulting in persistently elevated fasting blood glucose levels from day 3. Since there are few reports of STZ treatment in tree shrews, we determined the STZ dose mainly based on studies by
Liang et al 25 and short-term pre-experimental trials. We later found that a single application of 150 mg/kg STZ was excessive, resulting in animals in a poor condition. In order to increase the survival rate,
we treated the animals with insulin (when blood glucose was higher than 20 mmol/L) and glucose (when blood glucose was less than 1 mmol/L). The fasting blood glucose level was persistently elevated starting from day 3 in tree shrews ( Figure 1A ).
Insulin is the key factor regulating blood glucose absorption, which mainly affects liver, muscles and adipose tissues, promoting glucose usage and inhibition of glucose synthesis. By day 3 after application of STZ in rats, serum insulin was significantly increased.
However, the values at subsequent time points did not show a significant difference compared with the control group.
STZ treatment of tree shrews significantly increased the mean serum insulin levels at each time point compared with the control group ( Figure 1B ). These results suggest that insulin secretion persisted after STZ administration in rats and tree shrews. The insulin values were never less than in the control group, which was probably because the blood was sampled immediately after the glucose tolerance test.
| Changes in blood glucose levels following IPGTT
The glucose tolerance test measured changes in blood glucose after administration of glucose, to evaluate the effect of β-cell function and regulation of blood glucose levels. Similar variations in glucose levels were found in rats at each time point after administration of STZ (days 3, 7, 14, and 21) ( Figure 1C ). Blood glucose rose after administration of glucose, peaking at 60-90 minutes, and decreased to pre-treatment level after 2 hours. Compared with the control group, the baseline blood glucose value was significant raised. However, the blood glucose value peaked at a later stage after administration of glucose, indicating a slow recovery. These results suggest that STZ administration significantly decreased blood glucose regulation, and insulin secretion was deficient until day 21 post STZ.
Blood glucose variation in tree shrews was comparable to that of the control group on days 7, 14 and 21, following STZ treatment.
Blood glucose peaked at 10 minutes after administration, and was restored to pre-treatment levels at 60 minutes, or even below the pre-treatment level on days 7 and 21. On day 3 after administration of STZ, blood glucose varied from that of the control group, with levels persistently elevated after administration, and only slightly restored at 90 minutes ( Figure 1D ). These results suggest that after administration of STZ blood glucose regulation was maintained except on day 3. We speculate that the tree shrew is a highly active species, in which glucose utilization in peripheral tissues, especially skeletal muscle, is highly sensitive to insulin.
| STZ-mediated changes in islet morphology
HE staining of pancreatic sections showed that islets were scattered between pancreatic acini in controls. Pancreatic islets are elliptical or circular structures with a lucid structure, staining a light colour, and a clear boundary with the exocrine gland. In control tissue, the size of islets varied greatly, and giant islets were occasionaly observed ( Figure 2A ). The islets were generally small in normal tree shrew tissue; ultra-small islets (cell masses consisting of a few cells) were commonly found, while giant islets were not found ( Figure 2F ). The number of islets in each visual field was significantly larger in tree shrews than in rats (P < .05), and the mean islet area in tree shrews was significantly smaller than in rats (P < .05) ( Table 1) .
Three days after STZ treatment in rats, the number of islets was reduced. Islets were squeezed by exocrine pancreatic acini and had an irregular periphery, suggesting necrosis in a large number of β-cells and diminished islet area. Cells inside the islets were irregular and densely arranged in a few areas, with frequent signs of cell degeneration and necrosis ( Figure 2B ). Seven days after application of STZ, islet peripheries were still irregular in shape. Cell degeneration and necrosis were still visible in a few islets, and cell regeneration was clearly visible in a few islets ( Figure 2C ). At 14 days post STZ, islet peripheries and intra-islet cells were still irregular, with occasional cell degeneration, necrosis and regeneration ( Figure 2D ).
On day 21 post STZ, islet morphologies were signficantly restored.
However, cells were still densely arranged locally, with evident cell degeneration and necrosis ( Figure 2E ).
STZ treatment led to similar changes in islet morphology in tree shrews. However, 3 days after application of STZ, the number of islets was significantly reduced from normal, compared to rats. The degeneration and necrosis of intra-islet cells was more obvious, which was probably associated with the larger dose of STZ. By Figure 3B[f] ). On days 7 and 14, the distribution of insulin-positive staining was similar. However, positive staining was more commonly found in pancreatic tubular lumen ( Figure 3B [g]). On day 21, cell masses consisting of insulinpositive cells were found in exocrine centro-acinar cells ( Figure 3B [h]). In addition, image analyses showed that a much lower proportion of insulin-positive cells was found in the remaining islets after STZ application ( Figure 3C ).
In tree shrew controls, islet β-cells were distributed throughout the islets, forming the majority of cells ( Figure 3A[c] ). After 3 and 7 days post STZ, insulin-positive cells were found only in the remaining islets ( Figure 3A 
| Semi-quantitative analysis of glucagon expression
Islet α-cells secrete glucagon, so changes in islet α-cells were determined by observing glucagon-positive cells. In the control group of rats, islet α-cells accounted for about 30% of the tissue, and were mainly distributed in the peripheral regions of the islets ( Figure 4A [a]). During the entire observation period after application of STZ, glucagon secretion did not vary significantly. However, the distribution and proportion of islets varied. Starting at day 7 after STZ treatment, the proportion of α-cells in the islets increased, and the cells were distributed throughout the islets ( Figure 4A[b] ). Expression of α-cells after STZ treatment increased compared with that of the control group, but the difference was not statistically significant (P > .05) ( Figure 4B ). These results indicate that the replication and proliferation of islet β-cells were insignificant after injury. After absorption of necrotic cells, they were replaced by α-cells, resulting in diminished islet area.
In the tree shrew control group, after STZ treatment the proportion and distribution of islet α-cells, as well as changes in the islet α-cells, were similar to those in rats ( Figure 4A [c] and
However, the proportion of α-cells in the islets was higher than in rats, but was not significantly different compared with the control group (P > .05) ( Figure 4B ). These findings suggest that replication and proliferation of the injured islet β-cells in tree shrew were not significantly affected. However, the number of necrotic islet β-cells was higher than in rats, possibly due to the excessively large dose of STZ. Figure 5B ). In addition, positive PDX-1 expression was found in pancreatic interstitial cells ( Figure 5C [a]), and strong positive PDX-1 expression was detected in the dendritic cells of pancreatic lymph nodes in the tree shrew ( Figure 5C[b] ).
|

| DISCUSSION
Generally, STZ is used for treatment of metastatic islet cell adenoma.
Due to its selective toxicity for β-cells secreting insulin, it is often used to experimentally induce type 1 diabetes in animals, including islets. This was especially pronounced in rat tissue, which may be due to inter-species differences in sensitivity of islet β-cells to STZ toxicity. 28, 29 Our study showed that islets in rats were significantly restored after injury by STZ, which mainly occurred via regeneration of islet cells, proliferation of pancreatic centro-acinar cells and transformation of pancreatic ductal cells. Seven days after STZ treatment, significant islet cell regeneration was observed, and scattered cell regeneration was still visible at 14 days. Islets appeared to collapse from day 3 post injury, and were not significantly recovered by day 21, which indicated that the regenerated cells were limited in number, and were unable to completely replace the cells lost due to necrosis and absorption of β-cells. In addition, the islet α-cells were initially distributed in the peripheral areas of islets in the control group, while after STZ treatment, they increased in number and were distributed throughout the islets, which lasted until day 21 after administration, further confirming the above conclusion. self-replicating β-cells. 30 Lee et al developed a partial pancreatectomy model and a tracer method of BrdU uptake in animals to confirm the origin of regenerated β-cells via self-replication. 4 Chung et al used pancreatic duct ligation and simultaneous application of alloxan to show that the regenerated β-cells originated mainly from transformation of islet α-cells. 5 Bonner-Weir et al reported that replication was the main mechanism in adult animals, while regeneration of β-cells was also very common in young animals. 31 Other studies showed that, after injury of islet β-cells, the regenerated insulin-secreting cells derived mainly from centro-acinar cells of exocrine pancreas, which was first confirmed in zebrafish studies. | 159 metabolism. In summary, repair of injured islet β-cells in rats is dominated by regeneration and transformation of extra-islet cells, while replicated and regenerated intra-islet β-cells are limited in number.
Repair of the STZ-injured islets in tree shrews was not as extensive as in rats. On day 7 after STZ treatment, scattered regenerated cells were observed, which were not as obvious as in rats. Further, no regeneration of centro-acinar cells was observed. In addition, transformation of the insulin secretory function, visible in ductal epithelial cells, was also not as conspicuous as in rats. These results were similar to regeneration of islet β-cells in humans, 35 suggesting that the repair mechanism of islet β-cells injured by STZ in tree shrews may be similar to that in humans.
